Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Explore presentations by leading experts from iwNHL 2023 below. Click here to view the roundtable discussion for each of the sessions.
Session 1: T‐cell lymphoma
Session 2: Evolving frontline immune‐chemotherapy for MCL and the impact on survival outcomes
Session 3: Keynote address
Session 4: New pathogenetic mechanisms and therapeutic targets in DLBCL
*please note that no presentations are available from session 4 due to unpublished data
Session 5: Novel therapies part 1 – ADCs & menin inhibitors
Session 6: Expanding the CAR platform for NHL
Session 7: Novel therapies part 2: BTK inhibitors
Session 8: Bispecifics for NHL
iwNHL 2023 has been supported by: